{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32555127", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "14"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.12659/MSM.923163"], "Journal": {"ISSN": "1643-3750", "JournalIssue": {"Volume": "26", "PubDate": {"Year": "2020", "Month": "Jun", "Day": "18"}}, "Title": "Medical science monitor : international medical journal of experimental and clinical research", "ISOAbbreviation": "Med Sci Monit"}, "ArticleTitle": "Puerarin Inhibits Endothelium-Dependent Contractions in Mouse Carotid Arteries.", "Pagination": {"StartPage": "e923163", "MedlinePgn": "e923163"}, "Abstract": {"AbstractText": ["BACKGROUND Many bioactive ingredients of medicinal plants are known to produce vaso-protective benefits. Puerarin is one of the major isoflavone glucosides found in the root of kudzu vine and it exerts an anti-inflammatory effect and many other pharmacological actions. However, the mechanism underlying the vascular effect of puerarin is incompletely understood. Therefore, the present study aims to examine how puerarin reduces endothelium-dependent contractions (EDCs) in mouse arteries. MATERIAL AND METHODS EDCs were evoked by acetylcholine (ACh) in isolated mouse carotid arteries with intact endothelium pretreated with N\u03c9-NO2-L-Arg-OMe (L-NAME). The arteries were pretreated with puerarin and other pharmacological inhibitors before the addition of cumulative concentrations of ACh. The concentration of several prostaglandins (PGs) was measured by high performance liquid chromatography-coupled spectrometry (HPLC-MS). RESULTS EDCs induced by ACh only presented in endothelium-intact arteries pretreated by L-NAME and EDCs were prevented by the treatment with cyclooxygenase (COX) inhibitor indomethacin (3 \u00b5mol/L) or thromboxane prostanoid receptor (TP receptor) antagonist S18886 (30 nmol/L). Acute 40-minute treatment with puerarin reduced EDCs in a concentration-dependent manner without affecting U46619-induced contraction. However, treatment with puerarin did not inhibit ACh-induced production of prostaglandins (PGs) in endothelium-intact arteries. CONCLUSIONS The present results show that puerarin is able to suppress EDCs in mouse carotid arteries, independent of inhibition of TP receptor or COX2-derived PGs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China (mainland)."}], "LastName": "Chen", "ForeName": "Mei", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, Hong Kong."}], "LastName": "Xiang", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, Hong Kong."}], "LastName": "Wu", "ForeName": "Guangliang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China (mainland)."}], "LastName": "Liao", "ForeName": "Yingdi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China (mainland)."}, {"Identifier": [], "Affiliation": "School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, Hong Kong."}], "LastName": "Cai", "ForeName": "Yefeng", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Med Sci Monit", "NlmUniqueID": "9609063", "ISSNLinking": "1234-1010"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "EC 1.14.99.-", "NameOfSubstance": "Ptgs2 protein, mouse"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 1"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Ptgs1 protein, mouse"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}, {"RegistryNumber": "V55S2QJN2X", "NameOfSubstance": "NG-Nitroarginine Methyl Ester"}, {"RegistryNumber": "Z9W8997416", "NameOfSubstance": "puerarin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Carotid Arteries"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cyclooxygenase 1"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclooxygenase Inhibitors"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isoflavones"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle, Smooth, Vascular"}, {"QualifierName": [], "DescriptorName": "Myography"}, {"QualifierName": ["pharmacology"], "DescriptorName": "NG-Nitroarginine Methyl Ester"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vasoconstriction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Grueb M, Reinthal E, Rohrbach JM, et al. Muscarinic acetylcholine receptor subtypes in human corneal epithelium and endothelium. Graefes Arch Clin Exp Ophthalmol. 2006;244(9):1191\u201395.", "ArticleIdList": ["16506072"]}, {"Citation": "Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction and vascular disease \u2013 a 30th anniversary update. Acta Physiol (Oxf) 2017;219(1):22\u201396.", "ArticleIdList": ["26706498"]}, {"Citation": "Wong WT, Tian XY, Chen YC, et al. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res. 2010;107(8):984\u201391.", "ArticleIdList": ["20724703"]}, {"Citation": "Wong WT, Wong SL, Tian XY, et al. Endothelial dysfunction: The common consequence in diabetes and hypertension. J Cardiovasc Pharmacol. 2010;55(4):300\u20137.", "ArticleIdList": ["20422734"]}, {"Citation": "Wong SL, Leung FP, Lau CW, et al. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res. 2009;104(2):228\u201335.", "ArticleIdList": ["19096033"]}, {"Citation": "Dong J, Wong SL, Lau CW, et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J. 2012;33(23):2980\u201390.", "ArticleIdList": ["22267242"]}, {"Citation": "Tian XY, Wong WT, Leung FP, et al. Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2\u03b1) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal. 2012;16(4):363\u201373.", "ArticleIdList": ["PMC3584508", "21951274"]}, {"Citation": "Liang C, Zhang Y, Zhuo D, et al. Endothelial cell transient receptor potential channel C5 (TRPC5) is essential for endothelium-dependent contraction in mouse carotid arteries. Biochem Pharmacol. 2019;159:11\u201324.", "ArticleIdList": ["30414390"]}, {"Citation": "Baretella O, Vanhoutte PM. Endothelium-dependent contractions: Prostacyclin and endothelin-1, partners in crime? Adv Pharmacol. 2016;77:177\u2013208.", "ArticleIdList": ["27451098"]}, {"Citation": "F\u00e9l\u00e9tou M, Huang Y, Vanhoutte PM. Vasoconstrictor prostanoids. Pflugers Arch. 2010;459(6):941\u201350.", "ArticleIdList": ["20333529"]}, {"Citation": "Liu D, Liu B, Luo W, et al. A vasoconstrictor response to COX-1-mediated prostacyclin synthesis in young rat renal arteries that increases in prehypertensive conditions. Am J Physiol Heart Circ Physiol. 2015;309(5):H804\u201311.", "ArticleIdList": ["26209052"]}, {"Citation": "Virdis A, Bacca A, Colucci R, et al. Endothelial dysfunction in small arteries of essential hypertensive patients: Role of cyclooxygenase-2 in oxidative stress generation. Hypertension. 2013;62(2):337\u201344.", "ArticleIdList": ["23734008"]}, {"Citation": "Li XF, Yuan T, Xu H, et al. Whole-cell catalytic synthesis of puerarin monoesters and analysis of their antioxidant activities. J Agric Food Chem. 2019;67(1):299\u2013307.", "ArticleIdList": ["30558414"]}, {"Citation": "Zheng QH, Li XL, Mei ZG, et al. Efficacy and safety of puerarin injection in curing acute ischemic stroke: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017;96(1):e5803.", "ArticleIdList": ["PMC5228693", "28072733"]}, {"Citation": "Zhou YX, Zhang H, Peng C. Puerarin: A review of pharmacological effects. Phytother Res. 2014;28(7):961\u201375.", "ArticleIdList": ["24339367"]}, {"Citation": "Hu W, Yang X, Zhe C, et al. Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-\u03baB activation in LPS-induced RAW264.7 macrophage cells. Pharmacol Rep. 2011;63(3):781\u201389.", "ArticleIdList": ["21857089"]}, {"Citation": "Xiang Y, Wei X, Chen L, et al. Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes. J Mol Neurosci. 2014;52(4):577\u201385.", "ArticleIdList": ["24026619"]}, {"Citation": "Bian X, Sun B, Zheng P, et al. Derivatization enhanced separation and sensitivity of long chain-free fatty acids: Application to asthma using targeted and non-targeted liquid chromatography-mass spectrometry approach. Anal Chim Acta. 2017;989:59\u201370.", "ArticleIdList": ["28915943"]}, {"Citation": "Deng Y, Ng ES, Yeung JH, et al. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery. J Ethnopharmacol. 2012;139(1):294\u2013304.", "ArticleIdList": ["22120017"]}, {"Citation": "Li X, Lin Y, Zhou H, et al. Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension. Clin Exp Hypertens. 2017;39(1):58\u201364.", "ArticleIdList": ["28060542"]}, {"Citation": "Yeung DK, Leung SW, Xu YC, et al. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol. 2006;552(1\u20133):105\u201311.", "ArticleIdList": ["17027964"]}, {"Citation": "Lu XL, Liu JX, Wu Q, et al. Protective effects of puerarin against A\u03b240-induced vascular dysfunction in zebrafish and human endothelial cells. Eur J Pharmacol. 2014;732:76\u201385.", "ArticleIdList": ["24690262"]}, {"Citation": "Chen G, Pan SQ, Shen C, et al. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-\u03baB pathways. Acta Pharmacol Sin. 2014;35(4):463\u201375.", "ArticleIdList": ["PMC4813721", "24608673"]}, {"Citation": "Deng HF, Wang S, Li L, et al. Puerarin prevents vascular endothelial injury through suppression of NF-\u03baB activation in LPS-challenged human umbilical vein endothelial cells. Biomed Pharmacother. 2018;104:261\u201367.", "ArticleIdList": ["29775893"]}, {"Citation": "Shi W, Yuan R, Chen X, et al. Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS. Am J Chin Med. 2019;47(1):19\u201338.", "ArticleIdList": ["30612457"]}, {"Citation": "Liu B, Luo W, Zhang Y, et al. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol. 2012;97(2):277\u201389.", "ArticleIdList": ["22080487"]}, {"Citation": "Li S, Liu B, Luo W, et al. Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas. Clin Exp Pharmacol Physiol. 2016;43(1):67\u201374.", "ArticleIdList": ["26444418"]}, {"Citation": "Zhu N, Liu B, Luo W, et al. Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol. 2014;307(3):H319\u201327.", "ArticleIdList": ["24878773"]}, {"Citation": "F\u00e9l\u00e9tou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol. 2011;164(3):894\u2013912.", "ArticleIdList": ["PMC3195913", "21323907"]}, {"Citation": "Hwang YP, Kim HG, Hien TT, et al. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase. Toxicol Appl Pharmacol. 2011;257(1):48\u201358.", "ArticleIdList": ["21884717"]}, {"Citation": "Wang K, Zhu X, Zhang K, et al. Neuroprotective effect of puerarin on glutamate-induced cytotoxicity in differentiated Y-79 cells via inhibition of ROS generation and Ca(2+) influx. Int J Mol Sci. 2016;17(7) pii: E1109.", "ArticleIdList": ["PMC4964484", "27409614"]}]}], "History": [{"Year": "2020", "Month": "6", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["32555127", "PMC7325555", "10.12659/MSM.923163", "923163"]}}]}